Key EventSun Pharma secures global rights to lerodalcibep outside US and China
Key EventPostal ballot results approved by shareholders
ImpactShareholders have endorsed the proposed resolutions, indicating board confidence.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.73%·₹1,840
Key EventShareholders approved reclassification of promoter group to public category.
ImpactThe company will now report promoter holdings as part of the public shareholding in future filings.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.73%·₹1,840
Key EventTrading window closure announced for SUNPHARMA
ImpactShareholders must avoid trading during the restricted period to prevent insider‑trading violations.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·+1.14%·₹1,865
Key EventSun Pharma unveils FY26 investor presentation highlighting diversified revenue streams and profitability metrics
ImpactInvestors should note Sun Pharma's strong profitability expansion and diversified geographic revenue base driving sustainable growthSign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.38%·₹1,835
Key EventSun Pharma's subsidiaries settle antitrust litigation confidentially
ImpactThe settlement removes legal uncertainty but involves no disclosed financial impact.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.24%·₹1,864
Key EventSun Pharma incorporates wholly owned subsidiary in GIFT City
ImpactThe new subsidiary will centralize treasury functions for Sun Pharma's global operations.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.67%·₹1,868.5
Key EventMoody's and S&P Global assign investment-grade ratings to Sun Pharma post-Organon acquisition announcement
ImpactThe ratings validate Sun Pharma's strengthened global position but highlight integration risks and temporary leverage increase from the Organon deal.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·-0.26%·₹1,899
Key EventSun Pharma announces September 2026 investor meeting schedule
ImpactInvestors can engage directly with management in upcoming meetings without new price-sensitive disclosures.Sign up to read impact
Sun Pharmaceutical Industries Ltd (SUNPHARMA)
·Next Day Close·+0.13%·₹1,933
Key EventSun Pharma joins White House ceremony for U.S. medicine pricing commitments
ImpactThis partnership highlights Sun Pharma's deepening U.S. market commitment and potential long-term growth through pricing influence and strategic acquisitions.Sign up to read impact